Kangstem Biotech Co. Ltd (217730) - Total Liabilities

Latest as of September 2025: ₩11.60 Billion KRW ≈ $7.86 Million USD

Based on the latest financial reports, Kangstem Biotech Co. Ltd (217730) has total liabilities worth ₩11.60 Billion KRW (≈ $7.86 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 217730 cash flow metrics to assess how effectively this company generates cash.

Kangstem Biotech Co. Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how Kangstem Biotech Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 217730 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Kangstem Biotech Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Kangstem Biotech Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Millenium Hotels Real Estate I SOCIMI S.A. MC:YMHRE	Spain	€226.17 Million
Sagar Cements Limited NSE:SAGCEM	India	Rs26.38 Billion
INTEKPLUS Co. Ltd KQ:064290	Korea	₩85.45 Billion
Cohen & Steers Real Estate Opportunities and Income Fund NYSE:RLTY	USA	$143.70 Million
Invalda INVL AB STU:WTK	Germany	€23.41 Million
Aekyung Industrial Co Ltd KO:018250	Korea	₩82.54 Billion
SFC Energy AG XETRA:F3C	Germany	€58.61 Million
Crescendo Corporation Bhd KLSE:6718	Malaysia	RM551.21 Million

Liability Composition Analysis (2015–2024)

This chart breaks down Kangstem Biotech Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 217730 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	7.30	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.18	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.15	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kangstem Biotech Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kangstem Biotech Co. Ltd (2015–2024)

The table below shows the annual total liabilities of Kangstem Biotech Co. Ltd from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩12.80 Billion ≈ $8.68 Million	-65.15%
2023-12-31	₩36.74 Billion ≈ $24.90 Million	+10.21%
2022-12-31	₩33.33 Billion ≈ $22.59 Million	-4.97%
2021-12-31	₩35.07 Billion ≈ $23.77 Million	+13.56%
2020-12-31	₩30.89 Billion ≈ $20.93 Million	-28.04%
2019-12-31	₩42.92 Billion ≈ $29.09 Million	+68.30%
2018-12-31	₩25.50 Billion ≈ $17.28 Million	+13.65%
2017-12-31	₩22.44 Billion ≈ $15.21 Million	-8.27%
2016-12-31	₩24.46 Billion ≈ $16.58 Million	+553.16%
2015-12-31	₩3.75 Billion ≈ $2.54 Million	--

About Kangstem Biotech Co. Ltd

KQ:217730 Korea Biotechnology

Market Cap

$254.64 Million

₩375.75 Billion KRW

Market Cap Rank

#15620 Global

#603 in Korea

Share Price

₩3995.00

Change (1 day)

-1.11%

52-Week Range

₩1171.00 - ₩4615.00

All Time High

₩18836.30